Journal of Comparative Effectiveness Research

Aims & Scope

Healthcare is at a turning point.

We have entered a new era of high patient expectations, aging populations and socioeconomic constraints.

At the same time, attention is focusing more closely on personalized/precision medicine approaches to healthcare delivery, and healthcare options, especially in fields such as oncology, are proliferating.

The use of real-world evidence and big data offers the potential to harness vast amounts of medical data, but also brings significant methodological, legal and ethical challenges.

There is now a pressing need to make direct comparisons between the available healthcare options and interventions in order to address uncertainties in optimal clinical practice.

In this new environment, the goal of patient-centered outcomes research and comparative effectiveness research (CER) is to assist patients, physicians, purchasers, and policy makers to choose between the available options in order to improve healthcare delivery at the level of the individual and on a population scale.

The underlying question in undertaking comparative effectiveness research is – which treatment will work best, in which patient, and under what circumstances?

Against this backdrop, the peer-reviewed Journal of Comparative Effectiveness Research (ISSN: 2042-6305) provides a rapid-publication platform for debate, and for the presentation of new findings and research methodologies.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.5
2024	1.90

Journal Rank

Year	Value
2024	7991

Journal Citation Indicator

Year	Value
2024	731

SJR (SCImago Journal Rank)

Year	Value
2024	0.708

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	39

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Evaluating patient and stakeholder engagement in research: moving from theory to practice

  Citation: 366

  Authors: Laura, Emily, Alison

• Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement

  Citation: 262

  Authors: Patricia A, Danielle C, Priyanka J, Laura C, Scott D, David L, Sean R

• Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities

  Citation: 174

  Authors: Ian, Daniela, Ignacio, Chris, Jaheeda, Ray, Nick, Joanne, Jose M

• Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements

  Citation: 169

  Authors: Reeana, Gregg, Rosie

• Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

  Citation: 137

  Authors: Victoria, Sreeram V, Jack, Aaron, Xiaoyan, Xianying, Xuemei

• Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries

  Citation: 121

  Authors: Bertalan, Anett, Sándor, Kalman, András, Jonathan D, Zoltán

• Systematic overview of cost–effectiveness thresholds in ten countries across four continents

  Citation: 120

  Authors: Ruth, Ursula, Kim, Beate, Bernhard, Nikolai, Magdalena, Petra, Gaby, Martina, Imke, Ansgar, Karl, Andras, Diana, Uwe

• Efficacy classification of modern therapies in multiple sclerosis

  Citation: 101

  Authors: Imtiaz A, Evelyn, Christopher, Melody, Chris, Dieter A, Dee, Luisa, Nicholas

• Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study

  Citation: 99

  Authors: Eugenio, Francesco, Andrés Nascimento, Már, Filippo, Lauren P, Heather, Joel, Panayiota, Jin, Allan, Claudio L, Erik K, Craig M, Isabelle

• EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review

  Citation: 94

  Authors: Jasmine, Marko, Edward, David, Jennifer L, Dominic, Julia, Henry, Natalie, Andrew

---